Cleared Traditional

DeepRhythmAI (K241197) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241197 · Medicalgorithmics S.A. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
218d
Days
Class 2
Risk

K241197 is an FDA 510(k) clearance for the DeepRhythmAI. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Medicalgorithmics S.A. (Warsaw, PL). The FDA issued a Cleared decision on December 4, 2024 after a review of 218 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medicalgorithmics S.A. devices

Submission Details

510(k) Number K241197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2024
Decision Date December 04, 2024
Days to Decision 218 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 125d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 183
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K241197.
Affera Integrated Mapping System
K243892 · Medtronic, Inc. · Jan 2025
Mac-Lab (AltiX AI.i)
K243540 · Ge Medical Systems Information Technologies, Inc. · Dec 2024
Magnetic Localization Patch Kit (AFR-00021)
K243435 · Medtronic, Inc. · Dec 2024
Affera Integrated Mapping System
K241828 · Medtronic, Inc. · Nov 2024
Intra-Operative Positioning System (IOPS®) (Fiducial Tracking Pad)
K242133 · Centerline Biomedical, Inc. · Oct 2024
RHYTHMIA HDx™ Mapping System
K241227 · Boston Scientific Corporation · Aug 2024